EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Personalized multichannel transcranial direct current electrical stimulation ( tDCS ) in drug‐resistant epilepsy: A SEEG based open‐labeled study

Fabrice Bartolomei iD, Maëva Daoud, Megane Delourme iD, Sophie Tardoski, Julia Makhalova iD, Eya Bourguiba, Samuel Medina Villalon, Stanislas Lagarde iD, Fabrice Wendling, Giulio Ruffini, Ricardo Salvador, Francesca Pizzo und 1 weitere

Epilepsia Open · 2025

DOI: 10.1002/epi4.70055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia Open, 2025. Verfasst von Fabrice Bartolomei und 12 weiteren Autor:innen. Beteiligte Einrichtung: Epileptology and Cerebral Rhythmology Department, APHM, Timone Hospital, Marseille, France. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Transcranial Direct Current Stimulation, Epilepsies, Partial, Precision Medicine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the effects of personalized multichannel tDCS on seizure frequency, severity, quality of life, and psychiatric comorbidities in patients with drug‐resistant focal epilepsy. Secondary goals include assessing the safety and feasibility of this approach.

Methods

This open‐label pilot study involved 16 patients with drug‐resistant focal epilepsy. Patients underwent 3 cycles of personalized multichannel tDCS over 6 months, targeting the EZ defined by stereoelectroencephalography (SEEG). Each cycle consisted of five consecutive days of tDCS, with two daily sessions of 20 min each. The primary endpoint was a reduction in seizure frequency, with secondary endpoints addressing quality of life (QOLIE‐31 scores), seizure severity (NHS3 scores), and psychiatric comorbidities (NDDI‐E and GAD‐7 scales).

Results

Across all participants, a statistically significant 20% reduction in seizure frequency was observed ( p = 0.044). Six patients (37%) were identified as responders (≥50% seizure reduction), with one achieving seizure freedom. The mean seizure reduction among responders was 68%. Significant improvements were noted in overall quality of life (QOLIE‐31, p = 0.009), with greater benefits for patients with poorer baseline scores. No overall significant changes were observed in depression, anxiety, and seizure severity scores, though individual variability was noted. The treatment was well tolerated, with mild adverse events, primarily skin‐related. Significance Personalized multichannel tDCS shows promise as a noninvasive therapeutic option for drug‐resistant focal epilepsy, with benefits in seizure reduction and quality of life. Although results were variable, the method's safety and feasibility support further exploration through randomized controlled trials to refine protocols, better select potential responders' patients, and validate findings. Plain Language Summary This study tested a personalized brain stimulation technique called tDCS in people with difficult‐to‐treat epilepsy. The treatment led to fewer seizures in some patients and improved their quality of life. The approach was safe and caused only mild side effects. These results suggest that this type of noninvasive brain stimulation may be a helpful new option for people who do not benefit from medication or surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistant EpilepsyTranscranial Direct Current StimulationEpilepsies, PartialPrecision MedicineHumansFemaleMaleAdultQuality of LifePilot ProjectsMiddle AgedTreatment OutcomeYoung AdultElectroencephalographyAdolescent

Stichwörter der Autor:innen

brain stimulationepilepsy comorbiditiesneuromodulationquality of life in epilepsyseizure reductiontDCS

Autor:innen und Institutionen

  • Epileptology and Cerebral Rhythmology Department, APHM, Timone Hospital, Marseille, France.
  • Aix Marseille Univ, INSERM, INS, Inst Neurosci Syst, Marseille, France.
  • APHM, Health Research Direction, Marseille, France.
  • Univ Rennes, INSERM, Rennes, France.
  • Neuroelectrics Barcelona, Barcelona, Spain.

ORCID-Profile: Fabrice Bartolomei, Megane Delourme, Julia Makhalova, Stanislas Lagarde

Förderung

  • European Research Council

Zitieren

APA

Bartolomei, F., Daoud, M., Delourme, M., Tardoski, S., Makhalova, J., Bourguiba, E., Medina Villalon, S., Lagarde, S., Wendling, F., Ruffini, G., Salvador, R., Pizzo, F., & Giusiano, B. (2025). Personalized multichannel transcranial direct current electrical stimulation ( tDCS ) in drug‐resistant epilepsy: A SEEG based open‐labeled study. Epilepsia Open. https://doi.org/10.1002/epi4.70055

Vancouver

Bartolomei F, Daoud M, Delourme M, Tardoski S, Makhalova J, Bourguiba E, et al. Personalized multichannel transcranial direct current electrical stimulation ( tDCS ) in drug‐resistant epilepsy: A SEEG based open‐labeled study. Epilepsia Open. 2025. doi:10.1002/epi4.70055

BibTeX
@article{Bartolomei2025,
  author = {Bartolomei, Fabrice and Daoud, Maëva and Delourme, Megane and Tardoski, Sophie and Makhalova, Julia and Bourguiba, Eya and Medina Villalon, Samuel and Lagarde, Stanislas and Wendling, Fabrice and Ruffini, Giulio and Salvador, Ricardo and Pizzo, Francesca and Giusiano, Bernard},
  title = {Personalized multichannel transcranial direct current electrical stimulation ( tDCS ) in drug‐resistant epilepsy: A SEEG based open‐labeled study},
  journal = {Epilepsia Open},
  year = {2025},
  doi = {10.1002/epi4.70055}
}
Kostenlos starten →